Academy recognizes Dr. Costa’s outstanding contributions to the brain science of movement and learning that has yielded insights into Parkinson’s disease, autism and obsessive-compulsive disorder.
Findings reveal potential new strategy for treating people diagnosed with schizophrenia.
New SCAPE 2.0 system can serve as a critical tool to advance science and medicine.
Columbia research in mouse neurons reveals new insights into the biology of memory; offers promising new areas of focus to combat neurodegenerative diseases.
As part of Chan Zuckerberg Initiative's newly formed Seed Networks for the Human Cell Atlas, Columbia team will work to advance broad-scale efforts to treat spinal cord injury and disease.
Columbia’s Zuckerman Institute hosts gathering of leading neuroscientists from across the country
Columbia study highlights key role this gene plays in essential biological processes; offers promising new target for combating PTSD, a disorder that impacts women more than men.
Columbia-led discovery in mice aids efforts to map the circuitry of the brain’s learning center; stands to inform studies of psychiatric disorders in which this circuitry goes awry.
Columbia study in mice reveals importance of memory in driving key social behavior; offers insight into psychiatric disorders such as schizophrenia.
Meet the scientists leveraging technological advances to reveal aspects of the disease long hidden from view.
